Current status of ablative therapies in esophageal disorders.
Endoscopic ablative therapies for esophageal diseases have been used for palliation of inoperable esophageal cancer, but their use in eradication of early esophageal cancer and Barrett's esophagus (with and without dysplasia) has been reported in recent publications. Pharmacologic and surgical treatment of reflux symptoms in patients with Barrett's esophagus has not consistently reversed the metaplastic epithelium. This has led investigators to try different modalities of local injury to the columnar mucosa in an acid-reduced environment. Endoscopic reversal of Barrett's esophagus (visual replacement of columnar mucosa by squamous mucosa) is more readily achievable than complete histologic reversal. Preliminary data show that endoscopic reversal of Barrett's esophagus can be achieved, but intestinal metaplasia underlying the new squamous mucosa is reported in almost all series. Incidence of adenocarcinoma in patients with Barrett's without dysplasia is probably so low that endoscopic ablation as a therapy cannot be advocated outside of study protocols. Endoscopic therapy as a definitive treatment for patients with high-grade dysplasia (HGD) and/or early adenocarcinoma holds promise, especially in older patients with comorbid illnesses. Future long-term randomized studies are needed to determine whether ablative therapies can provide an alternative approach for patients with HGD and early cancer. Advanced cancers that are not resectable for cure can be effectively treated by endoscopic therapy for palliation of dysphagia.
Sharma
P
P
University of Kansas School of Medicine, Veterans Affairs Medical Center, 4801 East Linwood Boulevard, Kansas City, MO 64128-2295, USA. psharma@kumc.edu
D000230:Adenocarcinoma / Q000453:epidemiology / Q000601:surgery; D001471:Barrett Esophagus / Q000453:epidemiology / Q000601:surgery; D002294:Carcinoma, Squamous Cell / Q000453:epidemiology / Q000601:surgery; D016145:Endoscopy, Digestive System / Q000639:trends*; D004935:Esophageal Diseases / Q000453:epidemiology / Q000601:surgery*; D004938:Esophageal Neoplasms / Q000453:epidemiology / Q000601:surgery; D006801:Humans; D015994:Incidence; D012307:Risk Factors